177Lu-3PRGD2
an antineoplastic agent that targets integrin alphavbeta3; structure in first source
Also Known As:
177Lu-3PRGD(2)
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
Related Drugs and Biologics